Empirico
Anggie Becorest has a diverse background in operations management within the biotechnology and life sciences industry. Their experience includes roles such as SVP and Head of Operations at Empirico Inc., President and Co-Founder at Lab Asset Manager, and VP Operations at BioSurplus, Inc. Anggie also has a background in scientific research and development, having held positions such as Director of Research Operations at Neose Technologies and Manager of Glycosyltransferase Production at Cytel Corp. Additionally, they have been involved in community advocacy as a Cancer Center Community Advisory Board Member at Sanford Burnham Prebys and a National Board Member at Women In Bio.
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.